CAXTON CORP
Comparing Q4 2025 vs Q3 2025
Sorting applies to all holdings for this quarter on the server, then the page is sliced. Prior-quarter values come from the full prior-quarter filing.
Issuer ▲▼ | Shares | Value ($K) | ||||
|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | |
| SPYRE THERAPEUTICS INC | 0 | 8,919 | +8,919 | 0 | 292,194 | +292,194 |
| SPDR GOLD TR | 7,286 | 6,964 | -322 | 2,589,936 | 2,759,901 | +169,965 |
| X4 PHARMACEUTICALS INC | 0 | 15,557 | +15,557 | 0 | 62,227 | +62,227 |
| KYVERNA THERAPEUTICS INC | 22,981 | 18,773 | -4,208 | 137,887 | 176,468 | +38,581 |
| INHIBIKASE THERAPEUTICS INC | 16,393 | 28,453 | +12,060 | 26,557 | 58,328 | +31,771 |
| BERKSHIRE HATHAWAY INC DEL | 651 | 710 | +59 | 327,454 | 356,771 | +29,317 |
| LEXEO THERAPEUTICS INC | 17,332 | 13,943 | -3,389 | 115,084 | 138,453 | +23,369 |
| SAB BIOTHERAPEUTICS INC | 10,935 | 10,527 | -408 | 21,979 | 39,371 | +17,392 |
| CONTEXT THERAPEUTICS INC | 18,403 | 18,403 | 0 | 17,829 | 27,053 | +9,224 |
| COMPASS THERAPEUTICS INC | 53,503 | 29,495 | -24,008 | 187,260 | 158,386 | -28,874 |
| MIND MEDICINE MINDMED INC | 27,011 | 15,688 | -11,323 | 318,459 | 210,058 | -108,401 |